GET DAILY SIGNALSVivoPower (VIVO): Evaluating the Path to the $10 Price Target
Key Takeaways
- The $10 target stems from a single-source analyst estimate rather than a broad consensus of multiple analysts.
- VivoPower has limited sell-side coverage, with Yahoo Finance showing a one-year target of $10.00 and TipRanks indicating a "Moderate Buy" rating with about 146% upside from one analyst.
- From around $2.00, reaching $10 would imply roughly a 400% gain and a new all-time high above the 52-week peak of $6.86.
- The main support comes from the company's pivot to AI data-center infrastructure, highlighted by the Mo i Rana facility in Norway that recently helped swing results to profitability.
- Key risks include a large trailing net loss, a thin balance sheet, elevated volatility, and reliance on external financing.
- Explore more about VIVO's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages for a deeper look at the ticker's fundamentals and outlook.
- To see how AI-driven strategies are approaching stocks like VIVO, explore Trending AI Robots.
How the $10 Objective Was Set
VivoPower remains thinly covered, so the $10 figure cannot be viewed as a true multi-analyst consensus. Yahoo Finance lists a one-year target estimate of $10.00, while TipRanks shows a "Moderate Buy" rating with roughly 146% implied upside based on a single covering analyst. With fewer than two independent, current price targets available for a meaningful average, this level is best seen as one aggressively bullish data point circulating in public sources rather than the result of broad Wall Street input. The limited range of views gives the $10 mark less statistical weight than a standard consensus target would carry.
Current Market Position and Path to the Target
Trading near $2.00, the stock would need to advance about 400% to hit $10. That journey is made more challenging because $10 sits well above the 52-week range of $1.20 to $6.86, implying not just a recovery but a new record high. Recent price action has been volatile, with the shares trading above $4 in October before retreating toward $2. Fundamentals are still early-stage, with trailing revenue in the low millions and a fiscal 2026 net loss of roughly $49.7 million. The most recent quarter (Q1 fiscal 2027) showed an inflection point, however, with revenue near $6.8 million, a $600,000 net profit, and positive EBITDA of about $800,000. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
What Could Support a Move Toward the Target
The core bullish argument rests on the shift into AI data centers. The Mo i Rana facility in Norway accounted for about $6.5 million, or roughly 95%, of quarterly revenue through Bitcoin mining hosting and demand-response activities, delivering a gross margin near 37%. Management also closed a $50 million PIPE convertible preference share financing that bolsters near-term liquidity for capital-intensive work. A return to positive operating cash flow and a 69% reduction in general and administrative expenses point to a leaner cost base that could support further growth if data-center demand develops as anticipated.
What Could Prevent the Target From Being Reached
Significant hurdles remain. The company still reports a substantial trailing net loss and negative EPS, and its roughly $64 million market capitalization reflects meaningful execution risk. A capital-intensive data-center strategy depends on continued outside financing, which brings dilution and refinancing concerns. The electric-vehicle unit, Tembo, contributed only about $300,000 in the quarter, and planned separations of business units carry uncertain regulatory and timing outcomes. As a micro-cap with wide trading swings, VivoPower can experience sharp pullbacks on any earnings miss or financing setback.
Technical Levels and Market Structure
From a technical standpoint, the $6.86 level marks the key resistance zone as the 52-week and near all-time high. The $10 target sits about 46% above that prior peak. On the downside, the $1.20 area serves as the primary support floor, with intermediate swing levels near $1.69 and the recent $3.07 to $4.33 range. At roughly $2.00, the stock sits in the lower part of its longer-term range, so any sustained advance toward $10 would first require reclaiming several prior resistance zones.
Time Horizon and What Investors Should Monitor
Analyst price objectives typically reflect a roughly 12-month horizon, though the single-analyst coverage means that specific timeframe should not be taken as given. Investors should track quarterly revenue and EBITDA trends at the Mo i Rana site, gross margins in the data-center segment, deployment and terms of the PIPE financing, progress on the Tembo and Caret separations, and any additional analyst coverage or target updates. Given the company's dependence on external capital, financing announcements and cash-flow developments carry as much weight as headline revenue figures.
AI Daily Buy/Sell Signals
In my own research process, Tickeron's AI Daily Buy/Sell Signals have proven helpful for keeping tabs on names like VivoPower. These signals apply artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold recommendations based on shifting market conditions, technical patterns, and AI analysis. For a volatile micro-cap tied to AI infrastructure themes, such tools can assist in spotting opportunities and tracking trend changes more efficiently than manual review alone.
Final Assessment
The $10 objective for VivoPower is a single-source, aggressively bullish price target rather than a broad analyst consensus. Reaching it would require roughly a 400% advance from around $2.00 and would set a new all-time high, representing a substantial move. Support rests on the AI data-center pivot, the Mo i Rana facility, and the recent swing to positive EBITDA and operating cash flow. The main obstacles remain a deep trailing loss, a thin balance sheet, heavy financing dependence, and micro-cap volatility. Investors should view the target as one optimistic data point and monitor quarterly execution, financing terms, and analyst coverage before forming any conclusions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
VIVO sees its Stochastic Oscillator recovers from oversold territory
On November 09, 2026, the Stochastic Oscillator for VIVO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In 59 of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VIVO's RSI Indicator exited the oversold zone, 33 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Moving Average Convergence Divergence (MACD) for VIVO just turned positive on November 10, 2026. Looking at past instances where VIVO's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
Following a +30.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 184 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
VIVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIVO as a result. In 74 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 50-day moving average for VIVO moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.173) is normal, around the industry mean (16.360). P/E Ratio (-1.036) is within average values for comparable stocks, (53.310). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.434) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (104.492).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of diagnostic products
Industry ComputerCommunications
Advertisement